MASTEC INC - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by MASTEC, INC. on October 19, 2004, covering events occurring on September 8, 2004, and September 15, 2004. The filing pertains to corporate governance changes involving the election of new directors to fill vacancies on the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or pro forma information.
Material Changes
The primary material change reported is the appointment of two new individuals to the Board of Directors:
- Carlos M. de Cespedes: Elected on September 8, 2004, to fill a current vacancy. He serves as Chairman and CEO of Pharmed Group Holdings of Miami. His term ends at the 2004 Annual Meeting of Shareholders. He was not appointed to any committee at the time of election.
- Frank E. Jaumot: Elected on September 15, 2004, to fill another vacancy. He is a shareholder and Director of Accounting and Auditing for Ahearn, Jasco and Company, PA. His term ends at the 2004 Annual Meeting of Shareholders. He was appointed to the Audit Committee at the time of election.
The Company confirmed there are no arrangements or understandings regarding these elections other than standard compensation plans for non-employee Directors. No material transactions involving these individuals were reported since the beginning of the last fiscal year.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The report is limited to the disclosure of director elections and the attachment of related press releases.
Key Facts for Investor Verification
- Verify the qualifications and potential conflicts of interest for the new directors, specifically Carlos M. de Cespedes and Frank E. Jaumot.
- Confirm the composition of the Audit Committee following Mr. Jaumot's appointment.
- Review the attached press releases (Exhibits 99.1 and 99.2) for additional biographical details on the new directors.
- Note that this filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial metrics.